|
Volumn 4, Issue 7, 2014, Pages
|
New guidelines for HER2+ breast cancer
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
BRAIN NEOPLASMS;
BREAST NEOPLASMS;
DRUG EFFECTS;
DRUG RESISTANCE;
EVIDENCE BASED MEDICINE;
FEMALE;
GENETICS;
HUMAN;
PRACTICE GUIDELINE;
RADIATION RESPONSE;
RADIOTHERAPY;
SECONDARY;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
RADIOTHERAPY;
RECEPTOR, ERBB-2;
|
EID: 84921454390
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2014-078 Document Type: Article |
Times cited : (1)
|
References (0)
|